宜通世紀(300310.SZ)一季度淨利潤預降91.36%-120.15%
格隆匯3月6日丨宜通世紀(300310.SZ)公佈,預計2020年第一季度歸屬於上市公司股東的淨利潤-350萬元至150萬元,同比下降91.36%-120.15%。
報告期內,爆發的新型冠狀病毒感染肺炎疫情給公司網絡維護和網絡工程業務帶來一定的影響,由於各地封閉社區、交通管制,導致工程工期延長,維護工單完成率較低,預計會對公司一季度經營造成一定的影響。
另外,公司按併購協議在2018年末確認了可獲取的業績承諾方需補償的股份數仍有436.78萬股未回購註銷,此部分股票的公允價值變動將計入公允價值損益,屬於非經常性損益事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.